Peptide Guide + Calculator

KPV Reconstitution Calculator & Guide

α-MSH-Derived Tripeptide

KPV is the Lys-Pro-Val tripeptide derived from the C-terminal region of alpha-melanocyte-stimulating hormone. It is widely discussed online for inflammation and gut or skin recovery, but meaningful direct human therapeutic evidence is lacking. This guide explains the preclinical evidence, mechanism uncertainty, regulatory context, and educational concentration math.

Evidence Snapshot

KPV research at a glance

Standardized regulatory and evidence context so research compounds, investigational drugs, and approved medications are not treated as if they have the same level of human evidence.

Reviewed Sep 7, 2026

Regulatory status

Not FDA-approved

Development / evidence stage

Preclinical / no established therapeutic human evidence

Human evidence level

No meaningful direct human therapeutic evidence

Primary mechanism

Alpha-MSH-derived Lys-Pro-Val tripeptide studied for anti-inflammatory signaling in preclinical systems.

WADA context

Non-approved substance — S0 may apply

Primary targets

Inflammatory signaling; no validated therapeutic receptor target

What is a receptor?

Human intervention evidence

No robust human therapeutic trial program establishing oral, topical, or injectable KPV effectiveness was identified in the evidence base used for the guide.

Human biology evidence

Studies in human-derived keratinocytes and airway epithelial cells support mechanistic anti-inflammatory activity, but these are laboratory models rather than treated-patient trials.

Key takeaway

KPV has interesting alpha-MSH-derived anti-inflammatory biology, but meaningful direct human therapeutic evidence remains lacking.

Evidence labels describe the research base and regulatory context; they are not treatment, dosing, or use recommendations. Review dates describe the last BACToBasics source check for this evidence summary. Anti-doping rules can change and should be verified with the applicable authority.

KPV Reconstitution Calculator

Enter the vial amount, liquid volume, and amount you want to calculate. BACToBasics will automatically calculate concentration, liquid volume, and U-100 syringe-unit equivalents.

Loading calculator...

Calculator values are educational math inputs only. They are not recommended preparation amounts, doses, or use protocols.

KPV Reconstitution Math

Reconstitution math starts with the amount contained in the vial and the liquid volume used in the calculation. Dividing the vial amount by the liquid volume gives the resulting concentration.

Example vial amount

10 mg

Liquid VolumeCalculationConcentration
1 mL10 mg ÷ 1 mL10 mg/mL
2 mL10 mg ÷ 2 mL5 mg/mL
3 mL10 mg ÷ 3 mL3.3333 mg/mL

This table demonstrates concentration math only. The liquid volumes shown are examples for comparison and are not preparation recommendations.

More Reconstitution Tools

Need to compare different liquid volumes or convert between mg, mcg, mL, and U-100 units? Use the dedicated BACToBasics calculator tools.

What is KPV?

KPV stands for lysine-proline-valine, a three-amino-acid sequence derived from the C-terminal region of alpha-melanocyte-stimulating hormone, or alpha-MSH. Researchers have studied KPV because it appears to retain some anti-inflammatory effects associated with alpha-MSH without its pigmentary activity.

What does the evidence actually show?

Most KPV evidence comes from cell experiments, animal models, and mechanistic research. Studies in human-derived keratinocytes and bronchial epithelial cells have reported effects on inflammatory signaling, but those are laboratory models rather than trials demonstrating a therapeutic benefit in people.

KPV and inflammation

Experimental studies have explored KPV effects on pathways such as NF-kappaB signaling, cytokine release, and cellular inflammatory responses. Reviews of alpha-MSH-derived peptides describe KPV as a potentially useful anti-inflammatory sequence, but proposed therapeutic applications remain investigational.

KPV and gut-health claims

KPV is often marketed or discussed online for inflammatory bowel conditions and general gut repair. Preclinical gastrointestinal work is part of the reason for that interest, but there is not a robust clinical-trial evidence base establishing injectable or oral KPV as an effective human treatment for ulcerative colitis, Crohn's disease, or nonspecific gut symptoms.

KPV and skin research

Human keratinocyte experiments have helped characterize KPV signaling in skin cells, but cell-culture findings do not establish that topical or injected KPV improves eczema, wound healing, pigmentation disorders, or other skin conditions in clinical practice.

Regulatory and safety context

KPV is not an FDA-approved medication. Because meaningful direct therapeutic human evidence is lacking, there is also limited information defining pharmacokinetics, long-term safety, formulation quality, or clinically validated use patterns in people.

KPV reconstitution math

BACToBasics can calculate concentration from user-entered vial mass and liquid volume. The calculator does not imply that a particular KPV vial, route, dose, or schedule has been clinically validated.

Explore more about KPV

8 links

Comparisons, research records, development tracking, blends, and related guides are available here when you want to go deeper.

KPV FAQ

Tap a question to expand only the answer you want to read.

Is KPV FDA-approved?

No. KPV is not an FDA-approved medication.

Does KPV have human clinical trials?

Meaningful direct human therapeutic evidence is extremely limited. Much of the published KPV literature is preclinical or based on human-derived cells rather than treated patients.

Is KPV proven for gut inflammation?

No. Preclinical findings are interesting, but they do not establish KPV as a proven treatment for inflammatory bowel disease or general gut symptoms.

Is KPV related to Melanotan peptides?

KPV is derived from alpha-MSH, so it belongs to melanocortin-related biology, but it is structurally and functionally different from Melanotan II or bremelanotide.

Does BACToBasics provide KPV dosing?

No. The calculator is educational concentration math based on values the user enters; it does not recommend a dose or schedule.

Sources & References

3 sources

Open the references when you want to inspect the research and regulatory sources behind this guide.

1
Elliott et al. — KPV signaling in human keratinocytes, J Invest Dermatol 2004

Mechanistic study using human keratinocytes; not a therapeutic clinical trial.

2
Catania et al. — alpha-MSH and related tripeptides review, Endocrine Reviews 2008

Review of anti-inflammatory and protective effects of alpha-MSH-derived peptides including KPV.

3
Manna et al. — KPV in human bronchial epithelial cells, Br J Pharmacol 2012

Cellular study evaluating KPV effects on inflammatory signaling in human-derived airway epithelial cells.

BACToBasics provides educational information and math tools only. This content is not medical advice, dosing advice, injection instruction, or a recommendation to use any peptide or medication.